Vol. 30 No. Supplement 1 (2019): Volume 30 Issue S1 (2019)

Published: 2019-07-25

Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience

Bilgehan Aygen, Neşe Demirtürk, Orhan Yıldız, Mustafa Kemal Çelen, Ilhami Çelik, Şener Barut, Onur Ural, Ayşe Batırel, Reşit Mıstık, Funda Şimşek, Ali Asan, Gülden Ersöz, Nesrin Türker, Hüseyin Bilgin, Çiğdem Ataman Hatipoğlu, Faruk Karakeçili, A A

(10-15)

DOI: https://doi.org/10.5152/tjg.2019.07

PDF Abstract

Nonsirotic chronic hepatitis B presenting with hepatocellular carcinoma: a case report

Ahmet Uyanikoglu, Meliha Ozkutlu

(16-17)

DOI: https://doi.org/10.5152/tjg.2019.08

PDF Abstract

Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience

Nilay Danis, Husnu Pullukcu, Tansu Yamazhan, Galip Ersoz, Nalan Gülsen Unal, Fulya Gunsar, Ilker Turan, Zeki Karasu, Ulus Salih Akarca

(18-19)

DOI: https://doi.org/10.5152/tjg.2019.09

PDF Abstract

Retrospective Investigation of De novo hepatitis B infection in recipients after liver transplantation by anti-HBc positive donors

Murat Harputluoglu, Enes Malik Cecen, Murat Aladag, Kemal Baris Sarici, Ali Riza Caliskan, Mehmet Ali Erdogan, Osman Saglam, Sezai Yilmaz

(20-20)

DOI: https://doi.org/10.5152/tjg.2019.10

PDF Abstract

Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?

Safak Mirioglu, Selin Cakmak-Demir, Raim Iliaz, Hatice Celen-Ogunc, Filiz Akyuz, Kadir Demir, Fatih Besisik, Ilgin Ozden, Sabahattin Kaymakoglu

(21-22)

DOI: https://doi.org/10.5152/tjg.2019.11

PDF Abstract

A case of acute toxic hepatitis associated with Prangos ferulacea

Hakan Dursun, Fatih Albayrak, Ömer Yılmaz, Nihat Okçu

(23-23)

DOI: https://doi.org/10.5152/tjg.2019.12

PDF Abstract

Wild mushroom poisoning in Mersin: A retrospective epidemiological study and investigation of liver toxicity

Mustafa Zanyar Akkuzu, Orhan Sezgin, Seyran Bozkurt, Osman Özdoğan, Serkan Yaraş, Enver Üçbilek, Engin Altıntaş

(24-24)

DOI: https://doi.org/10.5152/tjg.2019.13

PDF Abstract

Evaluation of rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive treatment

Bilal Toka, Emel Gönüllü, Mukaddes Tozlu, Ahmet Tarik Eminler, Mustafa Ihsan Uslan, Aydın Şeref Köksal, Oğuz Karabay

(25-25)

DOI: https://doi.org/10.5152/tjg.2019.14

PDF Abstract

From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis

Jihad Aljabban, Kamal Khorfan, Merve Gurakar, Nabeal Aljabban, Hussam Salhi, Maryam Panahiazar, Dexter Hadley, Behnam Saberi

(26-28)

DOI: https://doi.org/10.5152/tjg.2019.15

PDF Abstract

Validation of ELF test score for hepatic fibrosis and evaluation in turkish chronic liver disease patients

Sertaç Durusoy, Ender Güneş Yeğin, Filiz Türe Özdemir, Çağlayan Keklikkıran, Osman Cavit Özdoğan

(29-29)

DOI: https://doi.org/10.5152/tjg.2019.16

PDF Abstract

Letrozole-induced hepatitis in 42-year-old woman with invasive ductal breast cancer

Nerma Custovic, Azra Husic Selimovic, Aida Saray, Dzanela Prohic, Timur Ceric, Aleksandra Duran, Jasmina Redzepagi, Sanjin Spreckic, Samra ato Mehmetbasic, Nadza Sivac

(30-30)

DOI: https://doi.org/10.5152/tjg.2019.17

PDF Abstract

Efficacy and safety of Paritaprevir/Ritonavir + Ombitasvir ± Dasabuvir ± Ribavirin in chronic hepatitis C patients with chronic renal failure

Fatih Güzelbulut, Ekrem Aslan, Ayça Gökçen Değirmenci Saltürk, Özgür Bahadır, Halil Şahin, Mevlüt Kiyak, Emine Kanatsız, Mustafa Keçeci

(31-32)

DOI: https://doi.org/10.5152/tjg.2019.18

PDF Abstract

Unusal case of imunlogical liver dissease coexisting with chronic calculous cholecystitis and anatomical variation of billiary duct

Sanjin Spreckic, Azra Husic Selimovic, Nadza Sivac Burina, Nerma Custovic, Samra Cato Mehmebasic, Ira Tanica

(33-33)

DOI: https://doi.org/10.5152/tjg.2019.19

PDF Abstract

Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience

Aysun Kartal, Dilara Turan Gökçe, Mesut Gümüşsoy, Mehmet Berk Örüncü, Necati Örmeci, Cihan Yurdaydın, Hasan Özkan, Ramazan Idilman

(34-34)

DOI: https://doi.org/10.5152/tjg.2019.20

PDF Abstract

Diastolic dysfunction in patients with cirrhosis and the relationship between the clinical and laboratory findings and diastolic dysfunction

Mehmet Demir, Fatih Şen

(35-35)

DOI: https://doi.org/10.5152/tjg.2019.21

PDF Abstract

Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data

Mehmet Demir

(36-36)

DOI: https://doi.org/10.5152/tjg.2019.22

PDF Abstract

A rare case of hepatitis: Giant cell hepatitis

Derya Arı, Meral Akdoğan, Hale Gökcan, Bayram Yeşil, Nesrin Turhan

(37-37)

DOI: https://doi.org/10.5152/tjg.2019.23

PDF Abstract

Hepatitis b reactivation rate in patients using anti tnf theraphy: Evaluation of patients not received anti viral prophylaxis

Süleyman Sayar, Kemal Kürbüz, Çağatay Ak, Nermin Mutlu Bilgiç, Resul Kahraman, Hakan Demirdağ, Roni Atalay, Zuhal Çalışkan, Oğuzhan Öztürk, Hamdi Levent Doğanay, Kamil Özdil

(38-38)

DOI: https://doi.org/10.5152/tjg.2019.24

PDF Abstract

A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C

Nurten Nur Aydın, Firdevs Aksoy, Ilknur Yavuz, Serap Iskender, Arzu Altuncekic Yildirim, Ilknur Esen Yıldız, Iftihar Koksal

(39-40)

DOI: https://doi.org/10.5152/tjg.2019.25

PDF Abstract

Ophtalmic findings in autoimmune liver diseases: a single center experience

Celal Ulasoglu, Ozlem Turkyilmaz, Kenan Ozendi, Ebubekir Senates, Ilyas Tuncer

(41-41)

DOI: https://doi.org/10.5152/tjg.2019.26

PDF Abstract

Jobert syndrome ‘’ a rare cause of liver dysfunction’’

Salih Kılıç, Abdullah Mübin Özercan, Mehmet Yalnız, Ibrahim Halil Bahçecioğlu

(42-42)

DOI: https://doi.org/10.5152/tjg.2019.27

PDF Abstract

Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection

Antoni Sicras Mainar, Sabahattin Kaymakoglu

(43-45)

DOI: https://doi.org/10.5152/tjg.2019.28

PDF Abstract

Changing of HAV seroprevalence in special young age group (health vocational high school students)

Selma Tosun, Seher Ayten Coskuner, Hulya Bayık

(46-46)

DOI: https://doi.org/10.5152/tjg.2019.29

PDF Abstract

Long-term impact on health vocational high school students 20 years after national HBV vaccination

Selma Tosun, Seher Ayten Coskuner, Hulya Bayık

(47-47)

DOI: https://doi.org/10.5152/tjg.2019.30

PDF Abstract

The under water part of the iceberg: Anti-HCV positivity

Nilay Danis, Imre Altuglu, Ayse Arslan, Abdullah Murat Buyruk, Fulya Günsar, Aysin Zeytinoglu, Ulus Salih Akarca

(48-49)

DOI: https://doi.org/10.5152/tjg.2019.31

PDF Abstract

HBsAg seroclearance in the chronic hepatitis B patients whom naïve and nucleos(t)ide analogue-treated: a long-term follow-up study

Iftihar Koksal, Bengü Pakyurek, Gurdal Yilmaz

(50-50)

DOI: https://doi.org/10.5152/tjg.2019.32

PDF Abstract

Toxic hepatitis and hyponatremia: Case report

Bayram Yeşil, Hale Gökcan, Mahmut Yüksel, Sabite Kaçar, Derya Arı, Meral Akdoğan

(51-52)

DOI: https://doi.org/10.5152/tjg.2019.33

PDF Abstract

Transplant associated thrombotic microangiopathy after liver transplantation: A case report

Genco Gençdal, Hakan Ismail Sarı, Şule Namlı Koç, Serdar Aslan, Şerafettin Yazar, Ramazan Dönmez, Çiğdem Arıkan, Kamil Yalçın Polat, Murat Akyıldız

(53-54)

DOI: https://doi.org/10.5152/tjg.2019.34

PDF Abstract

Evaluation of 24-year followig results of patients with inactive hepatitis B

Irem Altas, Selma Tosun

(55-55)

DOI: https://doi.org/10.5152/tjg.2019.35

PDF Abstract

Sustained viral response to new HCV treatment (direct-acting antivirals) in the second year of treatment and evaluation of side effects

Seher Ayten Coskuner, Selma Tosun

(56-57)

DOI: https://doi.org/10.5152/tjg.2019.36

PDF Abstract

Evaluation of anti-HCV-positive HCV RNA-negative patients: Is it a safe condition?

Mustafa Zanyar Akkuzu, Serkan Yaraş, Siad Mohammed Adam, Engin Altıntaş, Orhan Sezgin

(58-58)

DOI: https://doi.org/10.5152/tjg.2019.37

PDF Abstract

Efficiency and safety of direct acting antivirals in chronic hepatitis C patients ınfected with genotype 2 and 3 in Turkey

Behice Kurtaran, Figen Sarıgül, Mehmet Çabalak, Sibel Kaya, Nagehan Didem Sarı, Hasan Karsen, Esra Zerdali, Rahmet Güner, Kamuran Türker, Nevin Ince, Fehmi Tabak, Hepcturkey Study Group

(59-60)

DOI: https://doi.org/10.5152/tjg.2019.38

PDF Abstract

Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey

Fehmi Tabak, Behice Kurtaran, Esra Zerdali, Selma Tosun, Şaban Esen, Nefie Çuvalcı Öztoprak, Kamuran Türker, Nagehan Didem Sarı, Yusuf Önlen, Tansu Yamazhan, Kenan Hızel, Hepcturkey Study Group

(61-62)

DOI: https://doi.org/10.5152/tjg.2019.39

PDF Abstract

Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome

Suna Yapali, Serap Yucel, Nevin Sariguzel, Murat Saruç, Hakan Umit Unal, Arzu Tiftikci, Eser Kutsal, Oguz Fatih Onder, Gurhan Sisman, Cem Aygun, Ozdal Ersoy, Safak Kiziltas, Bahattin Cicek, Nurdan Tozun

(63-63)

DOI: https://doi.org/10.5152/tjg.2019.40

PDF Abstract

Diagnostic value of computerized tomography ın differential diagnosis of liver nodules

Muhammed Bahaddin Durak, Hale Gökcan, Meral Akdoğan, Sabite Kaçar, Rıza Sarper Ökten, Mustafa Özdemir, Nesrin Turhan, Erdal Birol Bostancı, Musa Akoğlu, Ertuğrul Kayaçetin

(64-64)

DOI: https://doi.org/10.5152/tjg.2019.41

PDF Abstract

Clinical characteristics of hepatocellular carcinoma: Results from central Anatolian region of Turkey

Gülten Can Sezgin, Demet Çoşkun, Alper Yurci, Güven Kahriman, Ömer Özbakır, Kadri Güven, Mevlüt Başkol, Mehmet Yücesoy, Kemal Deniz, Şebnem Gürsoy

(65-65)

DOI: https://doi.org/10.5152/tjg.2019.42

PDF Abstract

Etiology of cirrhosis changing trends over the years: A single-center turkish experience

Aysun Kartal, Ramazan Idilman, Merve Aydoğan, Fatih Karakaya, Çağdaş Kalkan, Soner Önem, Mehmet Berk Örüncü, Necati Örmeci, Cihan Yurdaydın, Deda Xheni, Hasan Özkan

(66-66)

DOI: https://doi.org/10.5152/tjg.2019.43

PDF Abstract

Liver biopsy may not be the optimal option for assessing treatment efficacy in chronic hepatitis delta (CHD) infection

Aysun Kartal, Mehmet Berk Örüncü, Berna Savaş, Ramazan Idilman, Fatma Yavaş, Cihan Yurdadın

(67-67)

DOI: https://doi.org/10.5152/tjg.2019.44

PDF Abstract

Serum prolidase could be a marker for fibrosis/cirrhosis?

Ferzan Aydin, Ahmet Uyanikoglu, Çiğdem Cindoğlu, Idris Kirhan, Necati Yenice

(68-68)

DOI: https://doi.org/10.5152/tjg.2019.45

PDF Abstract

Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels

Osman Ozdogan, Serkan Yaras, Enver Ucbilek, Fehmi Ates, Orhan Sezgin, Engin Altintas

(69-69)

DOI: https://doi.org/10.5152/tjg.2019.46

PDF Abstract

A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon

Figen Sarigül Yildirim, Murat Sayan, Murat Sayan, Derya Seyman, Ozlem Elpek

(70-72)

DOI: https://doi.org/10.5152/tjg.2019.47

PDF Abstract

Prospective and Randomized Comparison of Tenofovir and Entecavir in Hepatitis B Reactivation Prophylaxis in Patients Receiving Immunosuppressive Therapy

Bilal Toka, Aydın Şeref Köksal, Ahmet Tarık Eminler, Mukaddes Tozlu, Mustafa Ihsan Uslan, Erkan Parlak

(73-73)

DOI: https://doi.org/10.5152/tjg.2019.48

PDF Abstract

Clinical and laboratory features of children with chronic hepatitis B infection: A single center results

Melike Emiroglu, Ayşe Yüksel, Meltem Gumus, Halil Haldun Emiroglu

(74-74)

DOI: https://doi.org/10.5152/tjg.2019.49

PDF Abstract

Acute liver ınjury in a patient with secondary syphilis and acute viral hepatitis B coinfection

Habibe Tülin Elmaslar Mert, Ertuğrul Topçu, Figen Kuloğlu, Filiz Akata

(75-75)

DOI: https://doi.org/10.5152/tjg.2019.50

PDF Abstract

Effect of sofosbuvir on QT interval and other electrocardiography (ECG) findings in patients with HCV related decompase cirrhosis

Mehmet Demir

(76-76)

DOI: https://doi.org/10.5152/tjg.2019.51

PDF Abstract

Intrahepatic cholangiocarcinoma ın young adult without risk factor

Abdullatif Sirin, Ozgur Olmez, Muhammet Mustafa Suveran, Ayse Nur Toksoz Yıldırım, Kubra Akan Ismayilov, Ebubekir Senates, Yasar Colak

(77-78)

DOI: https://doi.org/10.5152/tjg.2019.52

PDF Abstract

Investigation of the factors affecting the response of treatment ın patients treated with oral direct acting antiviral agents

Yucel Ustundag, Yonca Yilmaz Urun, Aydin Seref Koksal, Oguz Karabay, Bilal Toka, Ahmet Tarik Eminler, Ertugrul Guclu, Erkan Parlak

(79-80)

DOI: https://doi.org/10.5152/tjg.2019.53

PDF Abstract

Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients

Fatma Tuğçe Şah, Onur Keskin, Fatih Karakaya, Zeynep Ellik, Aysun Çalışkan Kartal, Esra Yurdcu, Mithat Bozdayı, Ramazan Idilman, Cihan Yurdaydın

(81-82)

DOI: https://doi.org/10.5152/tjg.2019.54

PDF Abstract

Effect of vitamin D levels and osteoporosis on survival in patients with chronic liver disease awaiting liver transplantation

Hale Gokcan, Meral Akdogan, Sabite Kacar, Sibel Ozbudak Demir, Pinar Cam, Rabia Daylak, Derya Oztuna, Mustafa Kaplan, Sedef Ozdal Kuran

(83-84)

DOI: https://doi.org/10.5152/tjg.2019.55

PDF Abstract

Awareness of hepatitis C

Ömer Öztürk, Ilyas Tenlik, Derya Arı, Hale Gökcan, Sabite Kaçar, Meral Akdoğan

(85-85)

DOI: https://doi.org/10.5152/tjg.2019.56

PDF Abstract

Diagnosis ways of chronic HBV cases

Selma Tosun, Seher Ayten Coskuner, Irem Altas

(86-86)

DOI: https://doi.org/10.5152/tjg.2019.57

PDF Abstract

Does HBsAg positivity change in pregnancy?

Gokhan Tosun, Selma Tosun, Funda Balaylar

(87-88)

DOI: https://doi.org/10.5152/tjg.2019.58

PDF Abstract

Thyroid manifestations in autoimmune liver diseases: a single center experience

Celal Ulasoglu, Gonca Tamer, Nilufer Tekin, Kenan Ozendi, Ebubekir Senates, Ilyas Tuncer

(89-90)

DOI: https://doi.org/10.5152/tjg.2019.59

PDF Abstract

Primary immune deficiency screening in patients with biopsy proven autoimmune liver diseases

Cem Simsek, Javanşir Vahabov, Fuad Mustafayev, Alper Baysal, Deniz Nazire Çağdaş Ayvaz, Tuğrul Pürnak, Halis Şimşek, Yasemin Balaban

(91-91)

DOI: https://doi.org/10.5152/tjg.2019.60

PDF Abstract

Comparison of antivirals in prophylaxis of HBV reactivation in patients receiving immunsuppressive therapy

M. Aladag, M. Harputluoglu, A.R. Caliskan, M.A. Erdogan, Y. Bilgic, O. Yildirim, Y.F. Cagin, Y. Seckin, M. Karincaoglu

(92-92)

DOI: https://doi.org/10.5152/tjg.2019.61

PDF Abstract

Elevation of liver enzymes in intensive care patients is significantly related with the increased mortality

Ezgi Yiğit, Tuğba Çetin, Gamze Taşkıran, Hamza Polat, Yalçın Gül, Çağlayan Keklikkıran, Osman Cavit Özdoğan

(94-94)

DOI: https://doi.org/10.5152/tjg.2019.62

PDF Abstract

Psychometric test compliance of patients with cirrhosis in the diagnosis of minimal hepatic encephalopathy

Cansu Gür, Beyhan Hirik, Betül Şahan, Feyza Üstüner, Canberk Sami Başıbüyük, Çağlayan Keklikkıran, Coşkun Özer Demirtaş, Tarık Kani, Osman Cavit Özdoğan

(95-96)

DOI: https://doi.org/10.5152/tjg.2019.63

PDF Abstract

The importance of HBV testing during pregnancy and immunization and current HBV situation of babies

Selma Tosun, Ilknur Esen Yildiz, Semra Sen, Kenan Ugurlu, Handan Alaylı, Aysenur Bahsi, Seher Ayten Coskuner

(97-99)

DOI: https://doi.org/10.5152/tjg.2019.64

PDF Abstract

Evaluation of diagnostic performance simple non-invasıve fibrosis markers in patients with chronic hepatitis B

Süleyman Sayar, Roni Atalay, Şuheda Çakmak, Gülçiçek Ayrancı, Kemal Kürbüz, Resul Kahraman, Zuhal Çalışkan, Hakan Demirdağ, Oğuzhan Öztürk, Kamil Özdil, Hamdi Levent Doğanay

(100-100)

DOI: https://doi.org/10.5152/tjg.2019.65

PDF Abstract

Can we predict hepatic encephalopathy? What do the hemogram parameters tell us?

Erkut Demirciler, Nilay Danış, Devrim Bozkurt, Pelin Ergün, Nevin Oruç, İlker Turan, Fulya Günşar, Galip Ersöz, Ulus Salih Akarca, Ömer Özütemiz, Zeki Karasu

(101-101)

DOI: https://doi.org/10.5152/tjg.2019.66

PDF Abstract

The evaluation of liver biopsy specimens of chronic hepatitis B patients using early tissue markers for Hepatocellular Carcinoma: Before and after the development of Hepatocellular Carcinoma

Yusuf Öztürk, Ömer Öztürk, Cenk Sökmensüer, Can Berk Leblebici, Yasemin Balaban, Halis Şimşek, Bülent Sivri, Hayrettin Köklü, Tuğrul Pürnak

(102-102)

DOI: https://doi.org/10.5152/tjg.2019.67

PDF Abstract

Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey

Seymur Aslanov, Murat Akyıldız, İlker Turan, Nilay Danış, Galip Ersöz, Fulya Günşar, Ömer Özütemiz, Ulus Salih Akarca

(103-105)

DOI: https://doi.org/10.5152/tjg.2019.68

PDF Abstract

Efficiency and safety of direct-acting antiviral in cirrhotic hepatitis C infection patients: Real-life data from Turkey

Yeşim Taşova, Tansu Yamazhan, Şaban Esen, Nefise Çuvalcı Öztoprak, Yusuf Önlen, Nagehan Didem Sarı, İlknur Esen Yıldız, Dilara İnan, Esra Zerdali, Rahmet Güner, Şener Barut, Hayat Kumbasar Karaosmanoğlu, Sibel Kaya, Nevin İnce, İlyas Dökmetaş, Fehmi Tabak, Hepcturkey Study Group

(106-107)

DOI: https://doi.org/10.5152/tjg.2019.69

PDF Abstract